SBC Medical Group Holdings (SBC) Common Equity (2022 - 2025)

SBC Medical Group Holdings has reported Common Equity for 4 years, with the latest figure at $248.3 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity rose 27.31% year-over-year to $248.3 million; the trailing twelve-month figure through Dec 2025 stood at $248.3 million (up 27.31% YoY), and the FY2025 full-year result was $248.3 million, up 27.31% from the prior year.
• Common Equity for Q4 2025 stood at $248.3 million, roughly flat from $248.0 million in the prior quarter.
• The five-year high for Common Equity was $248.3 million in Q4 2025, with the low at $103.3 million in Q1 2023.
• Historically, Common Equity has averaged $174.1 million across 4 years, with a median of $160.7 million in 2024.
• Annual changes were most pronounced in 2024 — Common Equity surged 67.62% — and 2025, when it rose 20.66%.
• SBC Medical Group Holdings' Common Equity stood at $107.9 million in 2022, then surged by 33.34% to $143.8 million in 2023, then jumped by 35.61% to $195.0 million in 2024, then climbed by 27.31% to $248.3 million in 2025.
• The last three Common Equity figures came in at $248.3 million (Q4 2025), $248.0 million (Q3 2025), and $244.7 million (Q2 2025), per Business Quant data.